A genotype directed dose-finding study of irinotecan (CPT-11) by groups of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer

Trial Profile

A genotype directed dose-finding study of irinotecan (CPT-11) by groups of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2006

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Colorectal cancer; Gastric cancer
  • Focus Adverse reactions; Pharmacogenomic
  • Most Recent Events

    • 07 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top